Live from the NIH registry
Studies recruiting near Lakewood right now
Top 25 of 1,599 recruiting studies, sorted by proximity — each links to its official registry page
Type 1 Diabetes REst for Metabolic Health
Type 1 Diabetes (T1D), Sleep Health
N/A
Interventional 50 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
N/A
Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (7.6 mi)
· Sponsor: University of Colorado, Denver
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: Nationwide Children's Hospital
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Ovarian Cancer, Advanced Ovarian Carcinoma
N/A
Interventional 240 participants sought
University of Colorado Cancer Center-Anschutz — Aurora, Colorado (15.3 mi)
· Sponsor: Dana-Farber Cancer Institute
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Denver, Colorado (7.6 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Sarah Cannon Research Institute at Colorado Blood Cancer Institute — Denver, Colorado (7.6 mi)
· Sponsor: Nurix Therapeutics, Inc.
Creative Arts Program to Reduce Burnout in Healthcare Professionals
Burn-Out Syndrome, Post-Traumatic Stress Disorder
N/A
Interventional 195 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
University of Colorado Denver — Aurora, Colorado (15.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Denver Arthritis Clinic - Lowry — Denver, Colorado (7.6 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Colorado Retina Associates, PLLC — Lakewood, Colorado (2.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Kaiser Permanente-Franklin — Denver, Colorado (7.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC)
Phase 1
Interventional 30 participants sought
SCRI at HCA HealthONE — Denver, Colorado (7.6 mi)
· Sponsor: SHY Therapeutics
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Phase 2
Interventional 84 participants sought
University of Colorado at Denver ( Site 0108) — Aurora, Colorado (15.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
University of Colorado School of Medicine: Barbara Davis Center for Diabetes — Aurora, Colorado (15.3 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Esophageal Cancer, Head and Neck Cancer
N/A
Observational 700 participants sought
University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
B Cell Lymphoma, NHL, Adult
Phase 1
Interventional 36 participants sought
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute — Denver, Colorado (7.6 mi)
· Sponsor: Verismo Therapeutics
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Phase 3
Interventional 300 participants sought
Orthopedic Centers of Colorado — Parker, Colorado (22.6 mi)
· Sponsor: Medipost, Inc.
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: Pfizer
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
University of Colorado Anschutz — Aurora, Colorado (15.3 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Sarcoma
Phase 2
Interventional 20 participants sought
University Of Colorado Hospital — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Non-Muscle Invasive Bladder Neoplasms
N/A
Observational 150 participants sought
Colorado Clinical Research — Lakewood, Colorado (2.0 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Denver, Colorado (7.6 mi)
· Sponsor: AstraZeneca
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries
Craniocervical Injuries
N/A
Interventional 80 participants sought
Ehren Dodson — Broomfield, Colorado (15.5 mi)
· Sponsor: Regenexx, LLC
One-4-ALL Initiative
Literacy, Burden, Caregiver
N/A
Interventional 100 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
DS-Connect®: The Down Syndrome Registry
Down Syndrome
N/A
Observational 100,000 participants sought
Linda Crnic Institute for Down Syndrome — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver